Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Mantle cell lymphoma

U.S. Food and Drug Administration (FDA)
Government / National / Research

FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL

July 27, 2020July 25, 2020 - by MyChesCo

The U.S. Food and Drug Administration recently approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded …

Read More

Most Read

  • Another 10 Movies Starring Chester County, PA
  • Court Finalizes Orders, Monetary Judgments Against Ringleaders of Sanctuary Belize Real Estate Investment Scheme
  • U.S. Postal Service Releases Updated 2020 Post-Election Analysis
  • Family Found Dead Inside West Whiteland Township Home
  • FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV
  • Use of Online or Web-based Scheduling Applications for Scheduling of COVID-19 Vaccination Appointments

Subscribe for Updates

Chester County Events

  • Cancer (Oncology) Massage
    • 01/26/2021
      Exton
  • Intro to Practical Defensive Pistol (Indoor)
    • 01/27/2021
      Elverson
  • Machinery Rescue Awareness and Operations
    • 01/30/2021
      West Chester
  • Basic First Aid
    • 01/31/2021
      Malvern
  • Pistol Level 1
    • 01/31/2021
      Malvern
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • Acting HUD Secretary Announces Extension of Eviction and Foreclosure Moratoriums
  • U.S. Department of Agriculture Announces Key Staff Appointments
  • West Chester-based Information Technology Company Reports Massive Worldwide Growth
  • Family Found Dead Inside West Whiteland Township Home
Copyright © 2021 MyChesCo.